StockData
Jazz Pharmaceuticals plc logo

Jazz Pharmaceuticals plc (JAZZ) income statement

JAZZNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 2, 2026Score 7/30119% above fair value
$230.26−6.19 (-2.62%)

Close on Nov 20, 2026Market cap $14.95BP/E 75.0Yield –

See a number that looks wrong?